Type 2 diabetes has traditionally been viewed as a disease driven by insulin resistance and declining pancreatic beta-cell function. However, researchers are now looking much deeper into the cell itself. Increasing evidence suggests that mitochondrial dysfunction in diabetes may be a key factor linking impaired energy production, chronic inflammation, oxidative …
Read More »GLP-1 Drugs and Parkinson’s Disease: Could Metabolic Therapy Influence Neurodegeneration?
What if a medication designed to lower blood sugar could also help protect the brain? That question is driving growing interest among researchers studying the connection between GLP-1 drugs and Parkinson’s disease. Scientists are now exploring whether therapies originally developed for type 2 diabetes and obesity may influence inflammation, neuronal …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.